Pall Opens New Centre of Excellence in India to Serve Fast-Growing Life Sciences Market
As part of its global initiative to align with customers worldwide, Pall Corporation inaugurated its newest Life Sciences Centre of Excellence in Bangalore, India. The Centre shall drive process optimization innovations for the global life sciences market to meet the evolving opportunities and challenges of this fast-growing industry throughout Asia. The new Centre includes a state-of-the-art proteomics laboratory to help customers speed the drug discovery process. It also houses a validation laboratory and a training facility with specialty experts to support Indian and regional customers as they increasingly enter the stringently regulated drug export market.
India was strategically chosen as the location for Pall's new Centre of Excellence in Asia because of the country's highly regarded reputation in life sciences spanning biopharmaceutical research, development and production.
The new Centre will provide the pharmaceutical, biotechnology and discovery markets throughout the region with a full range of total fluid management solutions to help them achieve their goals. Led by a highly specialized team of professionals, the new Centre joins other Pall Life Sciences Centres of Excellence throughout Europe and the Western Hemisphere in bringing together the latest technologies with process optimization knowledge and expertise. With the opening of the Centre, Pall Life Sciences also expands its customer technical support system.
Organizations
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
New discovery solves problem of anti-inflammatory substance

Elementar Analysensysteme GmbH - Langenselbold, Germany
Radioprotective Molecules - Blocking iodide transport by inhibiting the sodium iodide symporter

FluoRok - Oxford, United Kingdom
Akela and Nventa announce merger

VIBROTECH S.R.L. - Sassuolo, Italy
Caliper Life Sciences Launches Comprehensive Drug Discovery and Development Services Business
